Literature DB >> 15764655

The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.

M Germana Paterlini1, David D Thomas.   

Abstract

We have used molecular dynamics simulations to investigate the effect of phosphorylation and mutation on the cytoplasmic domain of phospholamban (PLB), a 52-residue protein that regulates the calcium pump in cardiac muscle. Simulations were carried out in explicit water systems at 300 K for three peptides spanning the first 25 residues of PLB: wild-type (PLB(1-25)), PLB(1-25) phosphorylated at Ser16 and PLB(1-25) with the R9C mutation, which is known to cause human heart disease. The unphosphorylated peptide maintains a helical conformation from 3 to 15 throughout a 26-ns simulation, in agreement with spectroscopic data. Comparison with simulations of a fourth peptide truncated at Pro21 showed the importance of the region from 17 to 21 in preventing local unfolding of the helix. The results suggest that residues 11-16 are more likely to unfold when specific capping motifs are not present. It is proposed that protein kinase A exploits the intrinsic flexibility of the 11-21 region when binding PLB. In agreement with available CD and NMR data, the simulations show a decrease in the helical content upon phosphorylation. The phosphorylated peptide is characterized by helix spanning residues 3-11, followed by a turn that optimizes the salt-bridge interaction between the side chains of the phosphorylated Ser-16 and Arg-13. Replacing Arg-9 with Cys results in unfolding of the helix from C9 and an overall decrease of the helical conformation. The simulations show that initiation of unfolding is due to increased solvent accessibility of the backbone atoms near the smaller Cys. It is proposed that the loss of inhibitory potency upon Ser-16 phosphorylation or R9C mutation of PLB is due to a similar mechanism, in which the partial unfolding of the cytoplasmic helix of PLB results in a conformation that interacts with the cytoplasmic domain of the calcium pump to relieve its inhibition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764655      PMCID: PMC1305473          DOI: 10.1529/biophysj.104.054460

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  30 in total

1.  Structural studies on phospholamban and implications for regulation of the Ca(2+)-ATPase.

Authors:  R J Mortishire-Smith; H Broughton; V M Garsky; E J Mayer; R G Johnson
Journal:  Ann N Y Acad Sci       Date:  1998-09-16       Impact factor: 5.691

2.  Effect of phosphorylation on alpha-helix stability as a function of position.

Authors:  Charles D Andrew; Jim Warwicker; Gareth R Jones; Andrew J Doig
Journal:  Biochemistry       Date:  2002-02-12       Impact factor: 3.162

Review 3.  The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases.

Authors:  L N Johnson; E D Lowe; M E Noble; D J Owen
Journal:  FEBS Lett       Date:  1998-06-23       Impact factor: 4.124

Review 4.  Statistical analysis of protein kinase specificity determinants.

Authors:  A Kreegipuu; N Blom; S Brunak; J Järv
Journal:  FEBS Lett       Date:  1998-06-23       Impact factor: 4.124

5.  Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP.

Authors:  M Asahi; E McKenna; K Kurzydlowski; M Tada; D H MacLennan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

6.  Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

Authors:  P Pollesello; A Annila; M Ovaska
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

7.  Helix-coil transition of PrP106-126: molecular dynamic study.

Authors:  Y Levy; E Hanan; B Solomon; O M Becker
Journal:  Proteins       Date:  2001-12-01

8.  Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation.

Authors:  J Zamoon; F Nitu; C Karim; D D Thomas; G Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

9.  Alpha-helical stabilization by side chain shielding of backbone hydrogen bonds.

Authors:  Angel E García; Kevin Y Sanbonmatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

10.  Physical reasons for the unusual alpha-helix stabilization afforded by charged or neutral polar residues in alanine-rich peptides.

Authors:  J A Vila; D R Ripoll; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

View more
  20 in total

1.  Phosphorylation-induced structural changes in smooth muscle myosin regulatory light chain.

Authors:  David Kast; L Michel Espinoza-Fonseca; Christina Yi; David D Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

2.  Molecular dynamics simulations reveal a disorder-to-order transition on phosphorylation of smooth muscle myosin.

Authors:  L Michel Espinoza-Fonseca; David Kast; David D Thomas
Journal:  Biophys J       Date:  2007-06-01       Impact factor: 4.033

3.  Thermodynamic and structural basis of phosphorylation-induced disorder-to-order transition in the regulatory light chain of smooth muscle myosin.

Authors:  L Michel Espinoza-Fonseca; David Kast; David D Thomas
Journal:  J Am Chem Soc       Date:  2008-08-21       Impact factor: 15.419

4.  Structure, dynamics, and ion conductance of the phospholamban pentamer.

Authors:  Christopher Maffeo; Aleksei Aksimentiev
Journal:  Biophys J       Date:  2009-06-17       Impact factor: 4.033

5.  Effect of membrane thickness on conformational sampling of phospholamban from computer simulations.

Authors:  Maryam Sayadi; Seiichiro Tanizaki; Michael Feig
Journal:  Biophys J       Date:  2010-03-03       Impact factor: 4.033

6.  Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.

Authors:  Neha Abrol; Pieter P de Tombe; Seth L Robia
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

7.  Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A.

Authors:  Delaine K Ceholski; Catharine A Trieber; Charles F B Holmes; Howard S Young
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

Review 8.  Structural dynamics of muscle protein phosphorylation.

Authors:  Brett A Colson; Simon J Gruber; David D Thomas
Journal:  J Muscle Res Cell Motil       Date:  2012-08-29       Impact factor: 2.698

9.  Probing the interaction of Arg9Cys mutated phospholamban with phospholipid bilayers by solid-state NMR spectroscopy.

Authors:  Xueting Yu; Gary A Lorigan
Journal:  Biochim Biophys Acta       Date:  2013-07-10

Review 10.  Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies.

Authors:  Christophe Chipot; François Dehez; Jason R Schnell; Nicole Zitzmann; Eva Pebay-Peyroula; Laurent J Catoire; Bruno Miroux; Edmund R S Kunji; Gianluigi Veglia; Timothy A Cross; Paul Schanda
Journal:  Chem Rev       Date:  2018-02-28       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.